Bright Minds: One of top 14 Psychedelics Start-ups
The year 2020 has been exceptional in many ways. The world faced the pandemic and experienced the lock down in this year. Due to the lock down, the economy of many countries suffered, and so the new start-ups, but Bright Minds raised good investment during this difficult time.
Bright Minds is one of the top 14 psychedelics start-ups that received record breaking funding. Though the year 2020 was difficult in many ways, it had the best conditions for psychedelics start-ups to grow. Founded in 2017, Bright Minds raised C$10 million ($7.8 million) funds. The company's approach appealed to the investors, and they find the start-up promising. Let's try to find out the reasons that the start-up looks so promising and what the changes it will bring;
Important Points that Make Bright Minds a Promising Start-up
Bright Minds is one of the most talked Psychedelics start-ups. It has been in the news for its different approach since it was founded in 2017. As the biotechnology company has been on for the top fundraiser in 2020, it must have some potential. Let's find out the reasons that the company has been so popular among the investors;
Different Approach
The present time is most suitable for the psychedelics companies to grow. People are becoming more vocal about mental illness. The pandemic has made them aware of their physical and mental health. The different approach of Bright Minds makes it a realistic start-up. The company is using modern tools to cure brain issues. Here the expert team is working to develop the next generation of serotonin drugs. The drug will heal the specific condition without any side effects.
Best Team
The success of a biotechnology company lies on the shoulders of its team, and Bright Minds understand this. It has some of the best professionals that have huge experience. The company has top scientists with an average of 25+ years of experience in drug development. The experiences and innovative thinkers in top positions make the company a promising start-up.
Clear Target
The biotechnology company has set clear targets to achieve. The professionals working here introduces the company's motto in such an easy language that anyone can understand it. The company is developing a more effective drug to cure mental illness. The already approved drugs do not heal one particular receptor and re-uptake the central nervous system. Hence it has some positive and a few negative effects on the patient's body. Many times the patients don't give a proper response to the drug. So the Bright Minds is working to develop a drug that heals a particular receptor. The drug will have more good effects on the patient's bode with no side effects.
The Conclusion
Bright Minds is a promising start-up as four of its discoveries are already in late pre-clinical stages, and three are in early pre-clinical stages. The company is working to cure mental illness, and this sector needs a revolution in terms of effective drugs with no or fewer side effects.
Comments
Post a Comment